<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Human bites: Evaluation and management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Human bites: Evaluation and management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Human bites: Evaluation and management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Larry M Baddour, MD, FIDSA, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marvin Harper, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Allan B Wolfson, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 31, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The evaluation and management of human bite wounds is discussed here.</p><p>Animal bite wounds are discussed separately. (See  <a class="medical medical_review" href="/d/html/7671.html" rel="external">"Animal bites (dogs, cats, and other mammals): Evaluation and management"</a>.)</p><p class="headingAnchor" id="H1768268647"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>It is estimated that 250,000 human bites occur each year in the United States; up to 25 percent of these injuries become infected [<a href="#rid1">1,2</a>]. However, data are limited regarding the true incidence of human bites. </p><p class="headingAnchor" id="H2024671917"><span class="h1">TYPES OF BITES</span><span class="headingEndMark"> — </span>Human bite wounds can occur because of incidental or purposeful injury [<a href="#rid3">3,4</a>]. </p><p>Incidental minor bite injuries include "love nips" (to the face, breasts, or genital areas) or self-inflicted wounds (such as paronychia due to nail biting or thumb-sucking) [<a href="#rid5">5,6</a>]. (See  <a class="medical medical_review" href="/d/html/5574.html" rel="external">"Paronychia"</a>.)</p><p>Purposeful bites are those in which the biter intended to bite another person or themselves or an injury occurred during a physical altercation between two individuals [<a href="#rid7">7</a>].</p><p>The types of bites that cause serious injury or infection include the following: </p><p class="headingAnchor" id="H3230319912"><span class="h2">Occlusal bites</span><span class="headingEndMark"> — </span>Occlusal bites are frank bites by human teeth. On exam, they appear as semicircular or oval areas of erythema or bruising; the skin may or may not be intact. The most common locations are the fingers, hands, or arms. </p><p>Occlusal bites occur most commonly in young children and adult women. In adolescents and adults, occlusal bites to the breasts or genitalia during sexual activity or assault may occur.</p><p>In children, occlusal bites typically occur on the face, upper extremities, or trunk as the result of aggressive play with another child; such wounds are often trivial [<a href="#rid8">8</a>]. However, a bite wound on a child may also be due to child abuse, as discussed below. (See <a class="local">'Obtaining a history'</a> below and <a class="local">'Physical examination'</a> below.)</p><p class="headingAnchor" id="H3592025890"><span class="h2">Clenched-fist injuries</span><span class="headingEndMark"> — </span>Clenched-fist injuries ("fight bites") are lacerations from a clenched fist of one person striking the teeth of another  (<a class="graphic graphic_figure graphicRef67311" href="/d/graphic/67311.html" rel="external">figure 1</a>). They occur most commonly in adolescent boys and adult men [<a href="#rid9">9,10</a>]. The lacerations are small (usually ≤15 mm) and are typically over the third and fourth metacarpophalangeal or proximal interphalangeal joints of the dominant hand.</p><p>Skin breaks over the knuckles can lead to the introduction of both skin and oral flora into the joints and fascial layers of the hand [<a href="#rid9">9,10</a>]. Many patients ignore these wounds until the onset of pain, swelling, or purulent discharge; as a result, these injuries are often complicated by established infection at the time patients seek medical attention. </p><p class="headingAnchor" id="H3"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Following a bite wound, patients may seek care for evaluation of the bite injury itself or for concern of infection. </p><p class="headingAnchor" id="H3490886228"><span class="h2">Obtaining a history</span><span class="headingEndMark"> — </span>We ascertain the circumstances and location of the bite(s) as well as the patient's symptoms, including any indicators of infection (eg, redness, swelling), alteration in function (eg, decreased range of motion), and neurovascular compromise (eg, weakness, numbness, excessive bleeding).</p><p>In addition, we assess the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Source of the bite</strong> <strong>–</strong> Most bites are due to another person. Self-inflicted bites that are intentional may be indicative of underlying psychiatric or other conditions [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Events preceding the bite</strong> <strong>–</strong> In adults, physical altercation or sexual activity are the most common sources of purposeful bites. Adults who report a bite wound acquired during sex should be asked whether the sex and the bite were consensual or due to assault. (See  <a class="medical medical_review" href="/d/html/2765.html" rel="external">"Evaluation and management of adult and adolescent sexual assault victims in the emergency department"</a>.)</p><p></p><p class="bulletIndent1">In children, the most common biter is another child, usually during play but sometimes during an altercation. Bite wounds in children can also be an indicator of abuse by an adult; the physical examination may provide clues to abuse, as described below. (See <a class="local">'Physical examination'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Date of last tetanus vaccination</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presence of bleeding from biter's mouth and human immunodeficiency virus (HIV), hepatitis B, and hepatitis C status, if known</strong> <strong>–</strong> The likelihood of transmission of bloodborne pathogens by a human bite is extremely low, but possible cases have been reported [<a href="#rid14">14-20</a>]. Transmission may be possible if the biter was bleeding from the mouth at the time of the bite and broke the skin of the bitten individual. (See <a class="local">'Preventing HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV)'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History of cardiac valve abnormalities or a prosthetic valve</strong> <strong>–</strong> Rarely, <em>Eikenella corrodens</em> (an organism present in human oral flora) causes endocarditis, usually in adults with abnormal or prosthetic heart valves. Intravenous drug use is a more common cause of <em>Eikenella</em> endocarditis than human bites [<a href="#rid21">21</a>]. More information on the microbiology of human bites and <em>Eikenella</em> endocarditis is found below and elsewhere. (See <a class="local">'Spectrum of antibiotic coverage'</a> below and  <a class="medical medical_review" href="/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'HACEK organisms'</a>.)</p><p></p><p class="headingAnchor" id="H3514012985"><span class="h2">Inspecting the wound</span></p><p class="headingAnchor" id="H222183790"><span class="h3">Wound preparation</span><span class="headingEndMark"> — </span>Upon presentation, bite injuries are cleansed to facilitate examination, allow for adequate visualization of the extent of injury, and prevent infection. Appropriate wound management is the most important factor for preventing infection [<a href="#rid3">3</a>]. </p><p>Initial wound preparation includes the following steps:</p><p class="bulletIndent1"><span class="glyph">●</span>Control bleeding (direct pressure should be applied to actively bleeding wounds).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clean wound with soap and water or an antiseptic solution (eg, <a class="drug drug_general" data-topicid="9801" href="/d/drug information/9801.html" rel="external">povidone iodine</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Irrigate with tap water or sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> and remove grossly visible debris (if present).</p><p></p><p>Cleaning the wound is often better tolerated in patients who present immediately after the bite compared with patients who have an infected wound. For patients with significant pain, local anesthesia may be required to facilitate initial wound care, as discussed separately. (See  <a class="medical medical_review" href="/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics"</a> and  <a class="medical medical_review" href="/d/html/6338.html" rel="external">"Clinical use of topical anesthetics in children"</a>.)</p><p>Detailed discussion of initial wound preparation is found separately. (See  <a class="medical medical_review" href="/d/html/6328.html" rel="external">"Minor wound evaluation and preparation for closure"</a>.)</p><p class="headingAnchor" id="H4014538362"><span class="h3">Physical examination</span><span class="headingEndMark"> — </span>Once the wound has been cleaned and bleeding is controlled, examine for the following (see  <a class="medical medical_review" href="/d/html/6328.html" rel="external">"Minor wound evaluation and preparation for closure", section on 'Evaluation'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Proximity of bite to joints, tendons, or bone and potential injury to adjacent structures. </p><p></p><p class="bulletIndent1">Hand wounds should be carefully examined to assess for damage to the underlying tendon sheath, fascia, joint capsule, and metacarpal head. Wounds over or near the metacarpophalangeal joints should be explored in the relaxed, fingers-extended, and the clenched-fist positions to ensure the wound does not involve tendons or communicate with a fracture or joint  (<a class="graphic graphic_picture graphicRef69232" href="/d/graphic/69232.html" rel="external">picture 1</a>). (See  <a class="medical medical_review" href="/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Human bites'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A clenched-fist injury requires evaluation of finger extensor mechanism function  (<a class="graphic graphic_figure graphicRef51038" href="/d/graphic/51038.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef60333" href="/d/graphic/60333.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/d/html/201.html" rel="external">"Finger and thumb anatomy", section on 'Major joints'</a>.)</p><p></p><p class="bulletIndent1">Evaluate active and passive extension at the metacarpophalangeal (MCP), proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints. Any limitations of active extension (ie, lack of full extension, "extensor lag") suggests an injury to the underlying structures. An inability to actively extend fully at the MCP but still hold the finger in full extension when passively extended suggests a sagittal band rupture. Evaluate for disruption of the central slip by positioning the PIP in 90-degerees flexion, the MCP and DIP in extension, applying resistance at the middle phalanx, and asking the patient to extent the PIP against that resistance (Elson test); weak extension with a taut, hyperextended DIP suggests central slip injury [<a href="#rid4">4,22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of neurovascular compromise distal to the wound.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Does the wound break the skin (ie, penetrates the dermis into subcutaneous tissue  (<a class="graphic graphic_figure graphicRef54157" href="/d/graphic/54157.html" rel="external">figure 4</a>)).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Retained foreign material (eg, tooth).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Circumference of the bite marks in children – A mark on a child with maxillary intercanine distance (distance between left and right canine from the outer edge of the tooth) &gt;2.5 cm suggests the bite came from an adult and should raise concern for child abuse  (<a class="graphic graphic_picture graphicRef69917" href="/d/graphic/69917.html" rel="external">picture 2</a>) [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/103420.html" rel="external">"Physical child abuse: Recognition", section on 'Inflicted bruises'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signs of infection, as discussed immediately below.</p><p></p><p class="headingAnchor" id="H1603373798"><span class="h2">Assessing for infection</span><span class="headingEndMark"> — </span>Infection can cause significant morbidity after human bites. Infection rate ranges from 2 percent for superficial wounds, less than 10 percent for occlusal bites, to over 25 percent for clenched-fist wounds or other hand wounds [<a href="#rid2">2,24,25</a>].</p><p>The likelihood of infection after a human bite is determined by the depth and location of the wound and host factors. In most cases, the first signs and symptoms of infection begin approximately 24 hours after the bite, but signs as early as two hours after the bite can occur in some cases [<a href="#rid26">26</a>]. </p><p>Bite wound infection may be superficial (eg, cellulitis, with or without abscess) or deep (abscess, septic arthritis, osteomyelitis, tenosynovitis, or necrotizing soft tissue infection):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs of superficial infection</strong> – Clinical manifestations of cellulitis include tenderness, erythema, swelling, and warmth; purulent drainage, lymphangitis, and/or fever may be present. An associated superficial abscess may present as a tender, erythematous, fluctuant nodule.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs of deep infection</strong> – In addition to the above manifestations, clues for deep infection include persistent or progressive pain several days following the initial injury, pain with passive movement, pain out of proportion to exam findings, crepitus, joint swelling, systemic illness (fever, hemodynamic instability), and persistent signs of infection despite initial wound care and antibiotic administration.</p><p></p><p class="bulletIndent1">The level of suspicion for deep infection should be increased for patients with immunosuppression (including diabetes) or neuropathy; these patients often present later in their course with increased risk of serious infection and limited pain on clinical exam. </p><p></p><p class="bulletIndent1">A patient with a clenched-fist injury and obvious purulence or significant soft tissue destruction should be presumed to have septic arthritis or osteomyelitis until the wound can be explored, typically in the operating room [<a href="#rid27">27</a>]. A wound with pain, swelling, erythema, or mild drainage but with good, painless joint mobility may not require surgical exploration but should be evaluated by a hand surgeon and may need magnetic resonance (MR) imaging to exclude deep infection.(See  <a class="medical medical_review" href="/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Human bites'</a>.)</p><p></p><p class="bulletIndent1">Clinical manifestations of wound infection and associated complications are described further separately. (See  <a class="medical medical_review" href="/d/html/110529.html" rel="external">"Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults"</a> and  <a class="medical medical_review" href="/d/html/7668.html" rel="external">"Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7654.html" rel="external">"Infectious tenosynovitis"</a> and  <a class="medical medical_review" href="/d/html/7662.html" rel="external">"Necrotizing soft tissue infections"</a>.)</p><p></p><p class="headingAnchor" id="H1151564009"><span class="h2">Ancillary tests</span></p><p class="headingAnchor" id="H2945339025"><span class="h3">Imaging</span><span class="headingEndMark"> — </span>We obtain plain radiographs in patients with clenched-fist injuries to evaluate for evidence of fracture, joint disruption, or retained foreign body (ie, tooth).</p><p>In patients with other types of bites that appear to be clinically uninfected, plain radiographs are typically unnecessary but may be obtained if the bite breaks the skin and bone/joint disruption and/or presence of a foreign body is suspected. </p><p>For patients with infected bites, MR imaging may help identify deep infection and tendon injury; ultrasound may help distinguish cellulitis from a drainable abscess. If a joint infection is strongly suspected, imaging may not be required and may delay surgical exposure and direct examination/washout and thus should be made in conjunction with surgical evaluation. (See  <a class="medical medical_review" href="/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Imaging'</a> and  <a class="medical medical_review" href="/d/html/6921.html" rel="external">"Imaging techniques for evaluation of the painful joint", section on 'Magnetic resonance imaging'</a> and  <a class="medical medical_review" href="/d/html/6336.html" rel="external">"Techniques for skin abscess drainage", section on 'Bedside ultrasonography'</a>.)</p><p class="headingAnchor" id="H3938999859"><span class="h3">Cultures (wound, blood)</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wound cultures</strong> – In patients with suspected infection, wound Gram stain and cultures should be obtained to identify the causative pathogen(s) and to guide antibiotic therapy. Specimens should be obtained at the time of debridement (preferably prior to initiation of antibiotics) and samples sent for both aerobic and anaerobic bacterial cultures. The microbiology laboratory should be notified that a human bite wound is the source, so they can use specific techniques to identify fastidious organisms, such as <em>E. corrodens</em>.</p><p></p><p class="bulletIndent1">In patients with clinically uninfected bite wounds, we do not obtain wound cultures because the results do not correlate with infection [<a href="#rid28">28</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood cultures</strong> – We obtain blood cultures in patients with fever or other signs of systemic infection and in immunocompromised patients with any signs of infection [<a href="#rid28">28,29</a>]. Patients who have underlying heart valve abnormalities and signs of systemic infection or endocarditis should have multiple sets of blood cultures and may warrant additional workup, as discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a>.) </p><p></p><p class="bulletIndent1">In patients without evidence of systemic infection, the yield of blood cultures is low, and the risk of false positives (eg, skin contamination) typically outweighs the benefit. </p><p></p><p class="headingAnchor" id="H383463198"><span class="h3">Laboratory tests</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Routine bloodwork</strong> – In patients with clinically uninfected bite wounds, we do not obtain laboratory tests. </p><p></p><p class="bulletIndent1">For patients with clinically infected bite wounds, laboratory studies (eg, complete blood count and serum inflammatory markers such as erythrocyte sedimentation rate, C-reactive protein) are reasonable if there is clinical concern for septic arthritis or other serious infection (eg, fasciitis). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limited role of HIV, hepatitis B, and hepatitis C testing</strong> – The likelihood of bloodborne pathogen transmission for a human bite is extremely low. If the clinical history suggests that transmission is possible, baseline and follow-up testing, as well as prophylaxis, may be indicated, as discussed below and elsewhere. (See <a class="local">'Preventing HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV)'</a> below and  <a class="medical medical_review" href="/d/html/3768.html" rel="external">"Management of nonoccupational exposures to HIV and hepatitis B and C in adults"</a>.) </p><p></p><p class="headingAnchor" id="H4"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Patients may seek care for evaluation of bite injury (in absence of infection) or established bite infection. </p><p class="headingAnchor" id="H2265415613"><span class="h2">Tetanus and bloodborne pathogen prophylaxis</span><span class="headingEndMark"> — </span>Although the risk is usually low, patients with human bites should undergo evaluation for tetanus or bloodborne pathogen post-exposure prophylaxis. </p><p>In addition, human bite wounds may be associated with transmission of viral pathogens including hepatitis B, hepatitis C, HIV, and herpes simplex virus [<a href="#rid14">14-19</a>].</p><p class="headingAnchor" id="H4191459868"><span class="h3">Tetanus prophylaxis</span><span class="headingEndMark"> — </span>Human bites are considered a tetanus-prone wound. In a fully vaccinated patient (ie, has had ≥3 doses of a tetanus toxoid-containing vaccine), administer a tetanus toxoid-containing vaccine only if their last dose was given ≥5 years ago (or if the date of their most recent vaccine is uncertain)  (<a class="graphic graphic_table graphicRef61087" href="/d/graphic/61087.html" rel="external">table 1</a>). In an unvaccinated or partially vaccinated patient, administer a tetanus toxoid-containing vaccine<strong> and</strong> <a class="drug drug_general" data-topicid="9983" href="/d/drug information/9983.html" rel="external">tetanus immune globulin</a>.</p><p>Further details about tetanus vaccination are found separately. (See  <a class="medical medical_review" href="/d/html/3897.html" rel="external">"Tetanus-diphtheria toxoid vaccination in adults"</a> and  <a class="medical medical_review" href="/d/html/2844.html" rel="external">"Diphtheria, tetanus, and pertussis immunization in children 6 weeks through 6 years of age"</a> and  <a class="medical medical_review" href="/d/html/2838.html" rel="external">"Diphtheria, tetanus, and pertussis immunization in children 7 through 18 years of age"</a>.)</p><p class="headingAnchor" id="H3688002821"><span class="h3">Preventing HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV)</span><span class="headingEndMark"> — </span>In general, the risk of contracting HIV, hepatitis B, or hepatitis C from a human bite is negligible, but possible transmissions have been reported [<a href="#rid14">14-19</a>]. Transmission may be possible if the biter was bleeding from the mouth at the time of the bite and broke the skin of the bitten individual. In this situation, which is essentially a percutaneous blood exposure, either the biter or the bitten could theoretically become infected, and prophylaxis may be appropriate, as discussed separately. (See  <a class="medical medical_review" href="/d/html/3768.html" rel="external">"Management of nonoccupational exposures to HIV and hepatitis B and C in adults"</a>.)</p><p class="headingAnchor" id="H1088429495"><span class="h2">Uninfected bites</span><span class="headingEndMark"> — </span>In a patient with no symptoms or signs of wound infection, management includes wound care and assessment for antibiotic, tetanus, and bloodborne pathogen prophylaxis. </p><p class="headingAnchor" id="H887455267"><span class="h3">Antibiotic prophylaxis</span></p><p class="headingAnchor" id="H3605358486"><span class="h4">Indications for prophylaxis</span><span class="headingEndMark"> — </span>Antibiotic prophylaxis is typically provided to patients whose wounds have an increased risk of infection, in agreement with expert guidelines [<a href="#rid30">30</a>]. </p><p>We suggest post-exposure antibiotic prophylaxis in patients whose wounds <strong>break the skin</strong> and have any of the following features [<a href="#rid30">30,31</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Involvement or proximity to deep structures (eg, tendon, bone, joint) or vascular graft</p><p class="bulletIndent1"><span class="glyph">●</span>Need for surgical repair or debridement </p><p class="bulletIndent1"><span class="glyph">●</span>Closure by primary intention (ie, the wound is sutured closed) or planned delayed primary closure, as discussed below (see <a class="local">'Wound closure'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Located on the hand, face, or genitals (including clenched-fist wounds) </p><p class="bulletIndent1"><span class="glyph">●</span>Located in areas of prior cellulitis or underlying venous and/or lymphatic compromise</p><p class="bulletIndent1"><span class="glyph">●</span>Immunocompromised patient (including diabetes)</p><p class="bulletIndent1"><span class="glyph">●</span>Patients at high risk for endocarditis (eg, prosthetic heart valve, certain congenital heart defects, heart transplant with valvular dysfunction) (see  <a class="medical medical_review" href="/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures", section on 'Which patients?'</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Bites that have not received any wound care for more than eight hours</p><p></p><p>In the absence of the above factors, we do not favor use of post-exposure antibiotic prophylaxis<em>.</em> However, some experts favor routine use of antibiotic prophylaxis for human bites, even in the absence of the above factors. Most wounds that do not develop signs of infection by three days and have no retained foreign body will likely not become infected.</p><p>Evidence for post-exposure antibiotics is limited. In one randomized study of 48 patients with human bites to the hand, infection developed in 46 percent of patients who did not receive antibiotic prophylaxis; no infection developed among the patients who did receive antibiotic prophylaxis [<a href="#rid24">24</a>]. A trial of 125 patients with low-risk (penetrated only the epidermis and did not involve hands or feet) human bite wounds found that antibiotics, compared with placebo, did not reduce infection rates (infection developed in only one patient) [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H1437710553"><span class="h4">Prophylactic antibiotic regimens</span><span class="headingEndMark"> — </span>We prefer <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> (875/125 mg every 12 hours in adults) for human bite prophylaxis. The first dose should be administered as soon as possible after the bite. </p><p>In a patient with a clenched-fist wound, some experts will administer one intravenous (IV) antibiotic dose followed by oral therapy [<a href="#rid27">27</a>]. This practice may provide more rapid attainment of therapeutic blood antibiotic concentrations, but evidence does not exist that it improves outcomes. (See <a class="local">'Intravenous regimens'</a> below.)</p><p>Antibiotic options for prophylaxis are the same as for treatment of infection, but the duration of prophylaxis is only three to five days  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>) [<a href="#rid30">30</a>]. (See <a class="local">'Oral regimens'</a> below.) </p><p class="headingAnchor" id="H3748290629"><span class="h3">Wound management</span></p><p class="headingAnchor" id="H4135961558"><span class="h4">Indications for surgical consultation</span><span class="headingEndMark"> — </span>Most human bites can be managed at the bedside. Surgical consultation is warranted in the following circumstances [<a href="#rid33">33</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Clenched-fist wounds ("fight bites") with associated fracture, joint disruption, retained foreign body, or abnormal extensor tendon examination (see  <a class="medical medical_review" href="/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Human bites'</a> and <a class="local">'Physical examination'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Complex facial lacerations (see  <a class="medical medical_review" href="/d/html/13875.html" rel="external">"Assessment and management of facial lacerations"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Deep wounds, especially if significant avulsion or amputation is present</p><p class="bulletIndent1"><span class="glyph">●</span>Wounds associated with neurovascular compromise</p><p></p><p class="headingAnchor" id="H172382957"><span class="h4">Clenched-fist injury wounds</span><span class="headingEndMark"> — </span>A wound caused by a clenched-fist injury ("fight bite") should be irrigated, debrided, and explored, either at the bedside or by a surgeon in the operating room. In a patient with a normal extensor tendon examination and radiographs, it is reasonable to perform a bedside procedure and arrange surgical follow-up within 48 hours. Traditionally, it was recommended that these wounds be routinely evaluated by a surgeon and managed in the operating room, but insufficient evidence exists that every noninfected fight bite will have a better outcome with formal debridement in the operating room [<a href="#rid4">4,27</a>]. For example, a study of 115 adult patients with noninfected fight bites, normal extensor tendon examinations, and unremarkable radiographs found that operative debridement was associated with a higher complication rate compared with bedside irrigation (64 versus 7 percent) [<a href="#rid27">27</a>]. Patients who presented &gt;24 hours after the injury had a higher complication rate and thus may be appropriate for surgical consultation.</p><p>A patient with a fight bite should receive prophylactic antibiotics, preferably intravenously for the first dose. (See <a class="local">'Prophylactic antibiotic regimens'</a> above.)</p><p class="headingAnchor" id="H1039940978"><span class="h4">Wound closure</span><span class="headingEndMark"> — </span>For most patients with human bite wounds, we suggest that the wounds be left open to heal by secondary intention rather than by primary closure, given the high risk of subsequent infection (see <a class="local">'Assessing for infection'</a> above). These wounds should undergo debridement of devitalized tissue, exploration for retained foreign material, copious irrigation, and have a dressing applied. </p><p>Primary closure is a reasonable alternative in a patient with a facial laceration, given the cosmetic importance of this area [<a href="#rid3">3,28,33</a>]. These wounds may be closed primarily if they are clinically uninfected and ≤24 hours old [<a href="#rid28">28</a>]. Wounds that are primarily closed should be cleaned following meticulous debridement and copious irrigation. We generally place nonabsorbing sutures in the skin (except for young children where removal would could be challenging and threaten the repair) and avoid placing subcutaneous sutures because foreign material increases the risk of infection [<a href="#rid28">28</a>]. Bite wounds should not be closed with tissue adhesive ("glue").</p><p>For a wound that may benefit from primary closure but is &gt;24 hours old, the patient may be started on prophylactic antibiotics with a plan for delayed primary closure after three to four days. Unless the clinician has extensive experience with delayed primary closure, referral to a surgeon or other wound expert is advised since additional debridement (eg, of excessive accumulated granulation tissue) may be necessary at the time of closure. The waiting period during delayed primary closure permits the host defense system to decrease bacterial load and to ensure that no infection develops, which is a contraindication to closure. (See  <a class="medical medical_review" href="/d/html/6328.html" rel="external">"Minor wound evaluation and preparation for closure", section on 'Delayed primary closure'</a>.)</p><p>Patients who undergo primary closure warrant post-exposure antibiotic prophylaxis. (See <a class="local">'Prophylactic antibiotic regimens'</a> above.)</p><p class="headingAnchor" id="H286935992"><span class="h2">Infected bites</span><span class="headingEndMark"> — </span>Patients with suspected wound infection are managed with antibiotic therapy, obtaining cultures, wound debridement, and tetanus and bloodborne pathogen prophylaxis, if indicated [<a href="#rid28">28</a>]. (See <a class="local">'Tetanus and bloodborne pathogen prophylaxis'</a> above.)</p><p class="headingAnchor" id="H2835326233"><span class="h3">Antibiotic therapy</span></p><p class="headingAnchor" id="H4195710817"><span class="h4">Choosing oral versus IV therapy</span><span class="headingEndMark"> — </span>Oral antibiotic therapy is effective for most patients with infected wounds.</p><p>In the following circumstances, we administer IV antibiotics:</p><p class="bulletIndent1"><span class="glyph">●</span>Sepsis</p><p class="bulletIndent1"><span class="glyph">●</span>Rapidly progressive (eg, over hours) erythema</p><p class="bulletIndent1"><span class="glyph">●</span>Progression after 48 hours of appropriate oral antibiotics</p><p class="bulletIndent1"><span class="glyph">●</span>Deep-space infection (eg, necrotizing fasciitis, septic arthritis, clenched-fist injury)</p><p class="bulletIndent1"><span class="glyph">●</span>Proximity of the bite to an indwelling device (eg, prosthetic joint, vascular graft)</p><p></p><p>In a patient who has lymphangitis or an immunocompromising condition, we have a lower threshold for choosing IV therapy because these patients may be at increased risk for rapid or systemic progression of their infection.</p><p>In a patient who presents to the emergency department with an infected wound but does not meet the above criteria, some experts will administer one IV antibiotic dose followed by oral therapy. This practice may provide more rapid attainment of therapeutic blood antibiotic concentrations, but evidence does not exist that it improves outcomes.</p><p class="headingAnchor" id="H3332621310"><span class="h4">Oral regimens</span><span class="headingEndMark"> — </span>For oral treatment of infected human bites, we suggest choosing a regimen that covers streptococci,<em> Staphylococcus aureus</em>,<em> E. corrodens</em>,<em> </em>and anaerobic bacteria. We use one of the following antibiotic regimens:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preferred agent</strong> – We prefer <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> (875/125 mg orally every 12 hours in adults; see table for pediatric dosing)  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alternative regimens</strong> – For a patient unable to take <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>, we suggest combination therapy with one agent that covers aerobic bacteria and another that covers anaerobes. </p><p></p><p class="bulletIndent1">For patients intolerant of beta-lactams, our favored regimen is dual therapy with <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (one double-strength tablet orally every 12 hours) plus <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> (500 mg orally three times a day); see table for pediatric dosing  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>). Additional options are listed in the table  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>), and selection may depend on the antibiotics' adverse effects. </p><p></p><p class="bulletIndent1">We do not provide empiric coverage against methicillin-resistant <em>S. aureus</em> (MRSA) except in patients with abscess, MRSA risk factors  (<a class="graphic graphic_table graphicRef53504" href="/d/graphic/53504.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef113301" href="/d/graphic/113301.html" rel="external">table 4</a>), or gram-positive cocci in clusters on Gram stain of the wound. Our preferred regimen for MRSA coverage is combination therapy with <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> (875 mg orally every 12 hours) <strong>plus either</strong> <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (one double-strength tablet orally every 12 hours) or <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg orally every 12 hours). Other antibiotics that cover MRSA are noted in the table  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>). Issues related to risk factors and treatment of MRSA are discussed further separately. (See  <a class="medical medical_review" href="/d/html/3176.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections"</a> and  <a class="medical medical_review" href="/d/html/3157.html" rel="external">"Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology"</a>.)</p><p></p><p>Although <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a> is an option for anaerobic coverage, we generally avoid it due to risk of <em>Clostridium difficile </em>infection. We also do not use it as monotherapy since it has no activity against <em>E. corrodens</em>, and streptococcal and staphylococcal resistance is possible, as discussed below and separately. (See <a class="local">'Spectrum of antibiotic coverage'</a> below and  <a class="medical medical_review" href="/d/html/110530.html" rel="external">"Acute cellulitis and erysipelas in adults: Treatment", section on 'Alternatives for serious beta-lactam allergy'</a>.) </p><p>Data from clinical studies are limited, and our antibiotic selections are primarily based on the typical microbiology of infected bite wounds. (See <a class="local">'Spectrum of antibiotic coverage'</a> below.)</p><p class="headingAnchor" id="H3761538477"><span class="h4">Intravenous regimens</span><span class="headingEndMark"> — </span>Our criteria for IV antibiotics are described above. (See <a class="local">'Choosing oral versus IV therapy'</a> above.)</p><p>Our preferred IV regimen for human bites is one of the following  (<a class="graphic graphic_table graphicRef80019" href="/d/graphic/80019.html" rel="external">table 5</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8745" href="/d/drug information/8745.html" rel="external">Ampicillin-sulbactam</a> (3 g IV every six hours in adults) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">Ceftriaxone</a> (2 g IV once daily in adults) <strong>plus</strong> <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> (500 mg IV every eight hours in adults)</p><p></p><p>We add IV <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a> to cover MRSA in patients who have severe illness, abscess, MRSA risk factors  (<a class="graphic graphic_table graphicRef53504" href="/d/graphic/53504.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef113301" href="/d/graphic/113301.html" rel="external">table 4</a>), or gram-positive cocci in clusters on Gram stain of the wound. </p><p>For patients with necrotizing skin infection (eg, fasciitis), empiric antibiotic coverage is typically broader and targets toxin. Necrotizing skin infections are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7662.html" rel="external">"Necrotizing soft tissue infections", section on 'Treatment'</a>.)</p><p>Once a patient has clinically responded to IV therapy, it is reasonable to de-escalate to oral therapy  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>), unless the patient has another indication for prolonged IV therapy (eg, septic arthritis, prosthetic joint infection, osteomyelitis). Management of such infections are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/7665.html" rel="external">"Prosthetic joint infection: Treatment", section on 'Antibiotic therapy'</a> and  <a class="medical medical_review" href="/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment", section on 'Antibiotic therapy'</a>.) </p><p class="headingAnchor" id="H2237738757"><span class="h4">Duration of treatment</span><span class="headingEndMark"> — </span>The regimen should be tailored to culture and susceptibility data, once available. However, because anaerobic organisms can be difficult to grow in culture, we continue anaerobic coverage for the full course of therapy, even if anaerobic bacteria did not grow on culture.</p><p>The total duration of therapy is based on severity of infection and the patient's clinical response. In general, antibiotic therapy should be continued at least one to two days after symptoms and signs have resolved, which is typically less than seven days. </p><p>Most infections require no more than 14 days of therapy, but deep or complicated infections may require longer durations, particularly if a joint or bone is involved [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/7654.html" rel="external">"Infectious tenosynovitis"</a> and  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults"</a> and  <a class="medical medical_review" href="/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment"</a>.)</p><p class="headingAnchor" id="H3516857801"><span class="h4">Spectrum of antibiotic coverage</span><span class="headingEndMark"> — </span>The spectrum of antibiotics for human bites are based on the pathogens most frequently isolated from infected wounds [<a href="#rid26">26,34</a>]. Scarce data are available to support specific antibiotic regimens for human bites; our suggestions are based on our clinical experience and generally agree with those of expert guidelines [<a href="#rid30">30</a>].</p><p>The best evidence is derived from a study of 50 patients with infected human bites that were cultured from 12 university-affiliated emergency departments in the United States in 2000 and 2001 [<a href="#rid26">26</a>]. The median number of isolates per wound culture was four (three aerobes and one anaerobe), and approximately half of the bites were classified as abscesses. </p><p>Antibiotic selection targets the most likely pathogens from human skin and oral flora:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Human skin flora</strong> – The most common pathogen that originated from human skin in the aforementioned study was <em>S. aureus</em>, which was isolated from 15 of 50 (30 percent) of infected bites; the proportion of <em>S. aureus </em>isolates that were methicillin-resistant was not described [<a href="#rid26">26</a>]. Group A <em>Streptococcus </em>(ie, <em>S. pyogenes</em>) was uncommon, isolated from only 14 percent of bites. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Human oral flora</strong> – Important human oral pathogens that caused infection included the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Streptococcal spp other than Group A </strong><strong><em>Streptococcus</em></strong> <strong>–</strong> <em>Streptococcus anginosus </em>group bacteria (ie, <em>S. anginosus</em>,<em> S. intermedius</em>,<em> </em>and <em>S. constellatus</em>) were isolated from 72 percent of human bites, the highest percentage of any microorganism [<a href="#rid26">26</a>]. These organisms are known to cause invasive infections and abscesses. </p><p></p><p class="bulletIndent2">Streptococcal isolates are highly susceptible to beta-lactam antibiotics. However, studies of other antibiotics reveal variable results for the <em>S. anginosus </em>group. For example, resistance rates to tetracyclines (eg, <a class="drug drug_general" data-topicid="9986" href="/d/drug information/9986.html" rel="external">tetracycline</a>, <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a>) ranging from 12 to 72 percent and to <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (TMP-SMX) of 2 to 45 percent have been reported [<a href="#rid26">26,35-37</a>]. Furthermore, isolates are often reported as susceptible to fluoroquinolones, but resistance can develop while on therapy [<a href="#rid26">26,38,39</a>]. More information on <em>S. anginosus </em>can be found separately. (See  <a class="medical medical_review" href="/d/html/3178.html" rel="external">"Infections due to the <i>Streptococcus anginosus </i>(<i>Streptococcus milleri</i>) group"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>Eikenella corrodens</em></strong> – This organism is isolated from 30 percent of human bites. <em>E. corrodens</em> are fastidious organisms that may be misidentified by the microbiology laboratory. The organism is part of the HACEK group of endocarditis-causing organisms, as discussed separately; however, most <em>Eikenella </em>endocarditis cases are associated with IV drug abuse as opposed to human bites. (See  <a class="medical medical_review" href="/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'HACEK organisms'</a>.)</p><p></p><p class="bulletIndent2">In vitro studies of clinical isolates show that <em>E. corrodens </em>is typically resistant to penicillinase-resistant penicillins (eg, <a class="drug drug_general" data-topicid="9349" href="/d/drug information/9349.html" rel="external">dicloxacillin</a>), first- and second-generation cephalosporins (eg, <a class="drug drug_general" data-topicid="9231" href="/d/drug information/9231.html" rel="external">cephalexin</a>), <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a>, <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a>, and aminoglycosides [<a href="#rid26">26,40-44</a>]. Such studies consistently reveal susceptibility to penicillin, <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a>, tetracyclines, fluoroquinolones, TMP-SMX, <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a>, and carbapenems [<a href="#rid26">26,40-43,45-47</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anaerobes</strong> <strong>–</strong> Anaerobes are present in at least half of infected wounds [<a href="#rid26">26</a>]. Specific isolates include <em>Prevotella</em> species, fusobacteria, <em>Veillonella </em>species, and peptostreptococci. Unlike dog and cat bites, <em>Bacteroides </em>spp are uncommon in human bites, occurring in &lt;5 percent [<a href="#rid48">48,49</a>].</p><p></p><p class="headingAnchor" id="H681164379"><span class="h3">Debridement and surgical consultation</span><span class="headingEndMark"> — </span>Debridement of infected tissue is an important component of management for infection associated with a human bite. If previously repaired, suture material should be removed. Associated abscess(es) should be drained. (See  <a class="medical medical_review" href="/d/html/15912.html" rel="external">"Basic principles of wound management", section on 'Wound debridement'</a> and  <a class="medical medical_review" href="/d/html/6336.html" rel="external">"Techniques for skin abscess drainage"</a>.)</p><p>Debridement can often be performed at the bedside. However, we obtain urgent surgical consultation for bite-associated infection for any of the following [<a href="#rid33">33</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Concern for necrotizing soft tissue infection (eg, rapidly progressive infection, crepitus)</p><p class="bulletIndent1"><span class="glyph">●</span>Clenched-fist injuries (these often require operative joint exploration) (see  <a class="medical medical_review" href="/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Human bites'</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Deep-space infection (eg, deep abscess, septic arthritis, osteomyelitis, pyomyositis)</p><p class="bulletIndent1"><span class="glyph">●</span>Hand flexor tenosynovitis</p><p class="bulletIndent1"><span class="glyph">●</span>Purulent facial infection with concern for cosmetic deformity</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent signs and symptoms of infection despite appropriate antibiotic therapy</p><p class="bulletIndent1"><span class="glyph">●</span>Infection associated with neurovascular compromise</p><p class="bulletIndent1"><span class="glyph">●</span>Retained foreign body that cannot be removed at the bedside </p><p></p><p>At the time of debridement or surgery, deep tissue samples should be obtained for culture, as described above. (See <a class="local">'Cultures (wound, blood)'</a> above.)</p><p>In general, infected bite wounds should be left open following debridement. Delayed primary closure may be appropriate for facial wounds, large lacerations, and disfiguring wounds, as described above. (See <a class="local">'Wound closure'</a> above.)</p><p class="headingAnchor" id="H626126048"><span class="h1">FOLLOW-UP CARE</span><span class="headingEndMark"> — </span>All patients with human bites require close follow-up. We examine all wounds two to three days after initial presentation, regardless of infection status or type of closure. A clenched-fist injury wound should be evaluated by a hand surgeon at least within two days. We instruct the patient (or caregivers) to be evaluated sooner if they are concerned that signs or symptoms of infection are developing or worsening (if already present). Afterwards, the frequency of follow-up is individualized based on extent of healing and need for suture removal (if indicated). Some experts will evaluate infected wounds daily until significant clinical improvement has been documented, but this may be onerous for the patient and unnecessary in a patient (or caregivers) who can reliably monitor the wound.</p><p>Signs of developing or worsening infection on follow-up examination should prompt further wound evaluation (with radiographic imaging and/or surgical consultation, if indicated), suture removal (if present), review of antibiotic regimen and culture results, and/or a switch to IV therapy.</p><p class="headingAnchor" id="H3505763694"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110086.html" rel="external">"Society guideline links: Skin and soft tissue infections"</a> and  <a class="medical medical_society_guidelines" href="/d/html/112694.html" rel="external">"Society guideline links: Human bites"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/4005.html" rel="external">"Patient education: Animal and human bites (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types of human bites</strong> – Occlusal bites are frank bites by human teeth; they appear as semicircular or oval areas of erythema or bruising and the skin may or may not be intact. A bite mark on a child with maxillary intercanine distance (distance between left and right canine from the outer edge of the tooth) &gt;2.5 cm suggests the bite came from an adult and should raise concern for child abuse  (<a class="graphic graphic_picture graphicRef69917" href="/d/graphic/69917.html" rel="external">picture 2</a>). (See <a class="local">'Types of bites'</a> above.)</p><p></p><p class="bulletIndent1">Clenched-fist injuries ("fight bites") occur when the clenched fist of one person strikes the teeth of another  (<a class="graphic graphic_figure graphicRef67311" href="/d/graphic/67311.html" rel="external">figure 1</a>); lacerations are typically over the third and fourth metacarpophalangeal or proximal interphalangeal joints of the dominant hand. These are highly prone to infection. (See <a class="local">'Clenched-fist injuries'</a> above and <a class="local">'Assessing for infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Wound preparation</strong> – Initial wound care helps to prevent infection and facilitates examination; it includes applying direct pressure to control any bleeding, cleansing and irrigating the wound, and removing any visible debris. (See <a class="local">'Wound preparation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical examination</strong> – Examine the wound for proximity to important structures (eg, bone, joints), depth, neurovascular compromise, foreign material, cosmetic implications, and signs of infection (including flexor tenosynovitis). Wounds over or near the metacarpophalangeal joints should be explored in the relaxed, fingers-extended, and the clenched-fist positions to ensure the wound does not involve tendons or communicate with a fracture or joint  (<a class="graphic graphic_picture graphicRef69232" href="/d/graphic/69232.html" rel="external">picture 1</a>). A clenched-fist injury requires evaluation of finger extensor mechanism function. (See <a class="local">'Physical examination'</a> above and <a class="local">'Assessing for infection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of imaging</strong> <strong>and cultures</strong> – We obtain plain radiographs in patients with clenched-fist injuries or if there is concern for fracture, joint disruption, or retained foreign body. Wound cultures should be obtained from infected wounds. (See <a class="local">'Ancillary tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tetanus and bloodborne pathogen prevention</strong> – For a patient fully vaccinated against tetanus, we administer a tetanus toxoid-containing vaccine only if their last dose was given ≥5 years ago (or if the date of their most recent vaccine is uncertain). For unvaccinated or partially vaccinated patients, we administer a tetanus toxoid-containing vaccine <strong>and</strong> <a class="drug drug_general" data-topicid="9983" href="/d/drug information/9983.html" rel="external">tetanus immune globulin</a>  (<a class="graphic graphic_table graphicRef61087" href="/d/graphic/61087.html" rel="external">table 1</a>). (See <a class="local">'Tetanus prophylaxis'</a> above.)</p><p></p><p class="bulletIndent1">The risk of transmission of HIV, hepatitis B, and hepatitis C from human bites is negligible but possible, especially if the biter was bleeding from the mouth at the time of the bite and broke the skin of the bitten individual. (See <a class="local">'Preventing HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV)'</a> above and  <a class="medical medical_review" href="/d/html/3768.html" rel="external">"Management of nonoccupational exposures to HIV and hepatitis B and C in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of uninfected bites</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic prophylaxis</strong> – In selected patients at risk of infection, we suggest post-exposure antibiotic prophylaxis (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). We use <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> (875/125 mg orally every 12 hours in adults for three to five days; see table for pediatric dosing)  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a>). Such patients include those whose wounds have any of the following features (see <a class="local">'Antibiotic prophylaxis'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Involvement or proximity to deep structures (eg, tendon, bone, joint) or vascular graft</p><p class="bulletIndent3"><span class="glyph">-</span>Need for surgical repair or debridement </p><p class="bulletIndent3"><span class="glyph">-</span>Closure by primary intention (ie, the wound is sutured closed) or planned delayed primary closure</p><p class="bulletIndent3"><span class="glyph">-</span>Located on the hand, face, or genitals (including clenched-fist wounds) </p><p class="bulletIndent3"><span class="glyph">-</span>Near a bone, joint (including prosthetic joints), or vascular graft</p><p class="bulletIndent3"><span class="glyph">-</span>Located in areas of prior cellulitis or underlying venous and/or lymphatic compromise</p><p class="bulletIndent3"><span class="glyph">-</span>Immunocompromised patient (including diabetes)</p><p class="bulletIndent3"><span class="glyph">-</span>Patients at high risk for endocarditis (see  <a class="medical medical_review" href="/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures", section on 'Which patients?'</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Bites that have not received any wound care for more than eight hours</p><p></p><p class="bulletIndent2">A patient with a clenched-fist wound should preferably receive the first dose intravenously.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Wound care</strong> – Most human bites can be managed at the bedside. Surgical consultation is warranted for clenched-fist wounds with associated fracture, joint disruption, retained foreign body, or abnormal extensor tendon examination; complex facial lacerations; deep wounds (especially if significant avulsion or amputation is present); and wounds with neurovascular compromise. (See <a class="local">'Indications for surgical consultation'</a> above.)</p><p></p><p class="bulletIndent2">For a clenched-fist wound with a normal extensor tendon examination and radiographs, it is reasonable to irrigate, debride, and explore at the bedside and arrange surgical follow-up within 48 hours. (See <a class="local">'Clenched-fist injury wounds'</a> above.)</p><p></p><p class="bulletIndent2">We suggest that most human bite wounds be left open to heal by secondary intention (rather than closed primarily), given the high risk for the development of infection (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). These wounds should undergo debridement of devitalized tissue, exploration for retained foreign material, copious irrigation, and have a dressing applied. Primary closure is a reasonable alternative in a patient with an uninfected facial laceration given the cosmetic importance of this area. (See <a class="local">'Wound closure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of infected bites</strong> – Most patients with infected bites can be managed as outpatients with oral antibiotics. </p><p></p><p class="bulletIndent1">We suggest treatment with <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> (875/125 mg orally every 12 hours in adults; see table for pediatric dosing) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Our preferred intravenous (IV) option is <a class="drug drug_general" data-topicid="8745" href="/d/drug information/8745.html" rel="external">ampicillin-sulbactam</a> (3 g IV every six hours). Other options are listed in the tables  (<a class="graphic graphic_table graphicRef69328" href="/d/graphic/69328.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef80019" href="/d/graphic/80019.html" rel="external">table 5</a>). (See <a class="local">'Antibiotic therapy'</a> above.)</p><p></p><p class="bulletIndent1">Our preferred regimens cover the most frequently isolated organisms from human bites and are well tolerated in most patients. Most patients do not require empiric coverage for methicillin-resistant <em>Staphylococcus aureus</em> (MRSA). (See <a class="local">'Spectrum of antibiotic coverage'</a> above and <a class="local">'Oral regimens'</a> above.) </p><p></p><p class="bulletIndent1">Selected patients (eg, infected clenched-fist injuries) may require IV and/or broader spectrum coverage, as described above. (See <a class="local">'Choosing oral versus IV therapy'</a> above.) </p><p></p><p class="bulletIndent1">Debridement of devitalized tissue, removal of foreign material, and drainage of abscess should be performed. Wounds should be left open to heal by secondary intention. Urgent surgical consultation is appropriate for infected clenched-fist injuries (these often require operative joint exploration), hand flexor tenosynovitis, deep space infections, purulent facial infections, and others. (See <a class="local">'Debridement and surgical consultation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bula-Rudas FJ, Olcott JL. Human and Animal Bites. Pediatr Rev 2018; 39:490.</a></li><li><a class="nounderline abstract_t">Rothe K, Tsokos M, Handrick W. Animal and Human Bite Wounds. Dtsch Arztebl Int 2015; 112:433.</a></li><li><a class="nounderline abstract_t">Aziz H, Rhee P, Pandit V, et al. The current concepts in management of animal (dog, cat, snake, scorpion) and human bite wounds. J Trauma Acute Care Surg 2015; 78:641.</a></li><li><a class="nounderline abstract_t">Kennedy SA, Stoll LE, Lauder AS. Human and other mammalian bite injuries of the hand: evaluation and management. J Am Acad Orthop Surg 2015; 23:47.</a></li><li><a class="nounderline abstract_t">Fallouji MA. Traumatic love bites. Br J Surg 1990; 77:100.</a></li><li><a class="nounderline abstract_t">Wolf JS Jr, Gomez R, McAninch JW. Human bites to the penis. J Urol 1992; 147:1265.</a></li><li><a class="nounderline abstract_t">Henry FP, Purcell EM, Eadie PA. The human bite injury: a clinical audit and discussion regarding the management of this alcohol fuelled phenomenon. Emerg Med J 2007; 24:455.</a></li><li><a class="nounderline abstract_t">Schweich P, Fleisher G. Human bites in children. Pediatr Emerg Care 1985; 1:51.</a></li><li><a class="nounderline abstract_t">Moran GJ, Talan DA. Hand infections. Emerg Med Clin North Am 1993; 11:601.</a></li><li><a class="nounderline abstract_t">Phair IC, Quinton DN. Clenched fist human bite injuries. J Hand Surg Br 1989; 14:86.</a></li><li><a class="nounderline abstract_t">Singh SP, Aggarwal A, Kaur S, Singh D. Self inflicted human teeth bites: a case report. Pan Afr Med J 2014; 19:353.</a></li><li><a class="nounderline abstract_t">Komagoe S, Azumi S, Hasegawa Y. Self-inflicted human bite followed by hand necrotizing fasciitis in an adult with Down syndrome. Clin Case Rep 2020; 8:699.</a></li><li class="breakAll">American Academy of Child and Adolescent Psychiatry. Self-injury in adolescents. No.73; Jan 2019. https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Self-Injury-In-Adolescents-073.aspx (Accessed on September 28, 2023).</li><li><a class="nounderline abstract_t">Figueiredo JF, Borges AS, Martínez R, et al. Transmission of hepatitis C virus but not human immunodeficiency virus type 1 by a human bite. Clin Infect Dis 1994; 19:546.</a></li><li><a class="nounderline abstract_t">Bartholomew CF, Jones AM. Human bites: a rare risk factor for HIV transmission. AIDS 2006; 20:631.</a></li><li><a class="nounderline abstract_t">Shapiro CN. Transmission of hepatitis viruses. Ann Intern Med 1994; 120:82.</a></li><li><a class="nounderline abstract_t">Vidmar L, Poljak M, Tomazic J, et al. Transmission of HIV-1 by human bite. Lancet 1996; 347:1762.</a></li><li><a class="nounderline abstract_t">Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990; 336:503.</a></li><li><a class="nounderline abstract_t">Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989; 1:889.</a></li><li><a class="nounderline abstract_t">Akani CI, Uzoigwe S, Ariweriokuma B. Human bite and HIV transmission. Malawi Med J 2007; 19:90.</a></li><li><a class="nounderline abstract_t">Patrick WD, Brown WD, Ian Bowmer M, Sinave CP. Infective endocarditis due to Eikenella corrodens: Case report and review of the literature. Can J Infect Dis 1990; 1:139.</a></li><li><a class="nounderline abstract_t">Elson RA. Rupture of the central slip of the extensor hood of the finger. A test for early diagnosis. J Bone Joint Surg Br 1986; 68:229.</a></li><li><a class="nounderline abstract_t">Tsokos M. Diagnostic criteria for cutaneous injuries in child abuse: classification, findings, and interpretation. Forensic Sci Med Pathol 2015; 11:235.</a></li><li><a class="nounderline abstract_t">Zubowicz VN, Gravier M. Management of early human bites of the hand: a prospective randomized study. Plast Reconstr Surg 1991; 88:111.</a></li><li><a class="nounderline abstract_t">Jaindl M, Grünauer J, Platzer P, et al. The management of bite wounds in children--a retrospective analysis at a level I trauma centre. Injury 2012; 43:2117.</a></li><li><a class="nounderline abstract_t">Talan DA, Abrahamian FM, Moran GJ, et al. Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Clin Infect Dis 2003; 37:1481.</a></li><li><a class="nounderline abstract_t">Harper CM, Dowlatshahi AS, Rozental TD. Challenging Dogma: Optimal Treatment of the "Fight Bite". Hand (N Y) 2020; 15:647.</a></li><li><a class="nounderline abstract_t">Fleisher GR. The management of bite wounds. N Engl J Med 1999; 340:138.</a></li><li><a class="nounderline abstract_t">Oehler RL, Velez AP, Mizrachi M, et al. Bite-related and septic syndromes caused by cats and dogs. Lancet Infect Dis 2009; 9:439.</a></li><li><a class="nounderline abstract_t">Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014; 59:147.</a></li><li><a class="nounderline abstract_t">Medeiros I, Saconato H. Antibiotic prophylaxis for mammalian bites. Cochrane Database Syst Rev 2001; :CD001738.</a></li><li><a class="nounderline abstract_t">Broder J, Jerrard D, Olshaker J, Witting M. Low risk of infection in selected human bites treated without antibiotics. Am J Emerg Med 2004; 22:10.</a></li><li><a class="nounderline abstract_t">Kannikeswaran N, Kamat D. Mammalian bites. Clin Pediatr (Phila) 2009; 48:145.</a></li><li><a class="nounderline abstract_t">Goldstein EJ, Citron DM, Wield B, et al. Bacteriology of human and animal bite wounds. J Clin Microbiol 1978; 8:667.</a></li><li><a class="nounderline abstract_t">Băncescu G, Skaug N, Dumitriu S, Băncescu A. Antimicrobial susceptibility of some streptococci strains of anginosus group isolated from oral and maxillofacial infections. Roum Arch Microbiol Immunol 1999; 58:57.</a></li><li><a class="nounderline abstract_t">Kaplan NM, Khader YS, Ghabashineh DM. Laboratory Diagnosis, Antimicrobial Susceptibility And Genuine Clinical Spectrum of Streptococcus anginosus Group; Our Experience At A University Hospital. Med Arch 2022; 76:252.</a></li><li><a class="nounderline abstract_t">Thornton CS, Grinwis ME, Sibley CD, et al. Antibiotic susceptibility and molecular mechanisms of macrolide resistance in streptococci isolated from adult cystic fibrosis patients. J Med Microbiol 2015; 64:1375.</a></li><li><a class="nounderline abstract_t">Yamamoto N, Fujita J, Shinzato T, et al. In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus. Int J Antimicrob Agents 2006; 27:171.</a></li><li><a class="nounderline abstract_t">Kaneko A, Sasaki J, Shimadzu M, et al. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci. J Antimicrob Chemother 2000; 45:771.</a></li><li><a class="nounderline abstract_t">Li L, Shi YB, Weng XB. Eikenella corrodens infections in human: Reports of six cases and review of literatures. J Clin Lab Anal 2022; 36:e24230.</a></li><li><a class="nounderline abstract_t">Sofianou D, Kolokotronis A. Susceptibility of Eikenella corrodens to antimicrobial agents. J Chemother 1990; 2:156.</a></li><li><a class="nounderline abstract_t">Goldstein EJ, Sutter VL, Finegold SM. Susceptibility of Eikenella corrodens to ten cephalosporins. Antimicrob Agents Chemother 1978; 14:639.</a></li><li><a class="nounderline abstract_t">Tami TA, Parker GS. Eikenella corrodens. An emerging pathogen in head and neck infections. Arch Otolaryngol 1984; 110:752.</a></li><li><a class="nounderline abstract_t">Sheng WS, Hsueh PR, Hung CC, et al. Clinical features of patients with invasive Eikenella corrodens infections and microbiological characteristics of the causative isolates. Eur J Clin Microbiol Infect Dis 2001; 20:231.</a></li><li><a class="nounderline abstract_t">Goldstein EJ, Citron DM. Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins. Antimicrob Agents Chemother 1984; 26:947.</a></li><li><a class="nounderline abstract_t">Luong N, Tsai J, Chen C. Susceptibilities of Eikenella corrodens, Prevotella intermedia, and Prevotella nigrescens clinical isolates to amoxicillin and tetracycline. Antimicrob Agents Chemother 2001; 45:3253.</a></li><li><a class="nounderline abstract_t">Coburn B, Toye B, Rawte P, et al. Antimicrobial susceptibilities of clinical isolates of HACEK organisms. Antimicrob Agents Chemother 2013; 57:1989.</a></li><li><a class="nounderline abstract_t">Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85.</a></li><li><a class="nounderline abstract_t">Goldstein EJ. New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. J Med Microbiol 1998; 47:95.</a></li></ol></div><div id="topicVersionRevision">Topic 7674 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30275032" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Human and Animal Bites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26179017" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Animal and Human Bite Wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25710440" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The current concepts in management of animal (dog, cat, snake, scorpion) and human bite wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25538130" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Human and other mammalian bite injuries of the hand: evaluation and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2302496" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Traumatic love bites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1569665" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Human bites to the penis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17582031" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The human bite injury: a clinical audit and discussion regarding the management of this alcohol fuelled phenomenon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3843432" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Human bites in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8359133" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hand infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2926230" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clenched fist human bite injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25932066" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Self inflicted human teeth bites: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32274039" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Self-inflicted human bite followed by hand necrotizing fasciitis in an adult with Down syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32274039" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Self-inflicted human bite followed by hand necrotizing fasciitis in an adult with Down syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7811879" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Transmission of hepatitis C virus but not human immunodeficiency virus type 1 by a human bite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16470132" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Human bites: a rare risk factor for HIV transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8250462" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Transmission of hepatitis viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8656918" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Transmission of HIV-1 by human bite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1975005" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hepatitis C virus transmitted by human bite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2564960" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Horizontal transmission of hepatitis B virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23878645" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Human bite and HIV transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22553457" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Infective endocarditis due to Eikenella corrodens: Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3958008" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Rupture of the central slip of the extensor hood of the finger. A test for early diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25772121" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Diagnostic criteria for cutaneous injuries in child abuse: classification, findings, and interpretation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2052637" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Management of early human bites of the hand: a prospective randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22607996" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The management of bite wounds in children--a retrospective analysis at a level I trauma centre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14614671" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30808240" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Challenging Dogma: Optimal Treatment of the "Fight Bite".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9887167" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The management of bite wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19555903" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bite-related and septic syndromes caused by cats and dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24947530" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11406003" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Antibiotic prophylaxis for mammalian bites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14724871" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Low risk of infection in selected human bites treated without antibiotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18832534" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mammalian bites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/744798" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Bacteriology of human and animal bite wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11845446" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Antimicrobial susceptibility of some streptococci strains of anginosus group isolated from oral and maxillofacial infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36313947" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Laboratory Diagnosis, Antimicrobial Susceptibility And Genuine Clinical Spectrum of Streptococcus anginosus Group; Our Experience At A University Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26408040" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Antibiotic susceptibility and molecular mechanisms of macrolide resistance in streptococci isolated from adult cystic fibrosis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16417990" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10837428" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35019186" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Eikenella corrodens infections in human: Reports of six cases and review of literatures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2199625" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Susceptibility of Eikenella corrodens to antimicrobial agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/363054" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Susceptibility of Eikenella corrodens to ten cephalosporins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6385938" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Eikenella corrodens. An emerging pathogen in head and neck infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11399011" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clinical features of patients with invasive Eikenella corrodens infections and microbiological characteristics of the causative isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6395802" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11600394" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Susceptibilities of Eikenella corrodens, Prevotella intermedia, and Prevotella nigrescens clinical isolates to amoxicillin and tetracycline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23403420" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Antimicrobial susceptibilities of clinical isolates of HACEK organisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9887159" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9879949" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
